MANGALAM GLOBAL ENTERPRISE
Back to Balance Sheet
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹549 Cr | ₹405 Cr | ₹422 Cr | ₹270 Cr | ₹221 Cr |
What is the latest Total Liabilities ratio of MANGALAM GLOBAL ENTERPRISE ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹549 Cr |
Mar2024 | ₹405 Cr |
Mar2023 | ₹422 Cr |
Mar2022 | ₹270 Cr |
Mar2021 | ₹221 Cr |
How is Total Liabilities of MANGALAM GLOBAL ENTERPRISE Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹549 Cr | 35.50 | |
Mar2024 | ₹405 Cr | -4.02 | |
Mar2023 | ₹422 Cr | 56.03 | |
Mar2022 | ₹270 Cr | 22.36 | |
Mar2021 | ₹221 Cr | - |
Compare Total Liabilities of peers of MANGALAM GLOBAL ENTERPRISE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANGALAM GLOBAL ENTERPRISE | ₹552.7 Cr | 5.2% | 15% | NA | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,504.7 Cr | -1.3% | -1.8% | -13.7% | Stock Analytics | |
KAVERI SEED COMPANY | ₹5,779.4 Cr | -7.1% | -14.7% | 13.5% | Stock Analytics | |
VENKYS (INDIA) | ₹2,247.0 Cr | -0.7% | -2.3% | -17.7% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,442.2 Cr | -2.5% | 0.2% | -34.5% | Stock Analytics | |
INDO US BIOTECH | ₹312.4 Cr | 2.5% | -1.5% | -30.9% | Stock Analytics |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANGALAM GLOBAL ENTERPRISE | 5.2% |
15% |
|
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses